Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hemophilia of Iowa (HOI) is a non-profit organization dedicated to improving the quality of life for individuals and families affected by hemophilia, von Willebrand disease, and other rare bleeding disorders throughout the state of Iowa. Established in 1974, the organization provides essential services including patient advocacy, educational programming, and emergency financial assistance for medical expenses. HOI works closely with Hemophilia Treatment Centers (HTCs) and healthcare providers to ensure patients have access to specialized care and the latest treatment information. The organization also fosters a supportive community through events such as family camps, educational seminars, and legislative advocacy efforts. As a chapter of the National Bleeding Disorders Foundation, HOI serves as a critical resource for the Iowa bleeding disorders community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hemophilia of Iowa.